⏰ Starting in 10 minutes! Join experts Drs. Sarah Van Tassel and Anu Laul for a live discussion on the crucial interplay between structural and functional changes in glaucoma. There’s still time – join us at ow.ly/1SOA50X19hn #sponsored

Watch the latest episode of Glaucoma Case Files as Drs. Simpson and Garakani discuss a patient’s complicated surgical history for neovascular glaucoma, and how they managed the patient’s IOP and pain symptoms with ECP and other strategies. Watch here: ow.ly/kflr50WXJHp

How do we expand options for patients with glaucoma? In this upcoming webinar, leading surgeons will share how a bio-interventional surgical approach can transform outcomes by enhancing the uveoscleral pathway. 📅 Don’t miss it—secure your spot now! ow.ly/vCYs50X5G7a #ad

I. Paul Singh, MD; Emily Schehlein, MD; and H. George Tanaka, MD, review a case from Dr. Singh's practice of a patient w/ glaucoma & history of SLT/MIGS. Find out what Dr. Singh did and how it compared w/ results of a social poll of GT’s audience: ow.ly/aXvY50X7bL0

.The Fundingsland Group Read this article to gain expert insights into the complementary roles of SLT and sustained-release drug delivery in early-stage glaucoma management: ow.ly/1V3E50X81Nr

Check out the newest issue of the Video Journal of Cataract, Refractive, and Glaucoma Surgery, presented by Dr. Robert Osher: ow.ly/lLkB50X9XZn

"In this issue of GT, we hear from #glaucoma surgeons who changed their thinking in recent years, sometimes pivoting from approaches that had been in use throughout their careers" - Chief Medical Editor Arsham Sheybani, MD. Continue on at GlaucomaToday.com

See Mitosol full prescribing information at mitosol.com/mitosol-packag… See Amphadase full prescribing information at eyeamphadase.com/wp-content/upl… #ad

Dr. Marjan Farid discusses the side effect profile associated with 0.4% pilocarpine ophthalmic solution (Qlosi, Orasis) in this clip from a recent episode of Innovation Journal Club. Watch the full episode here: ow.ly/sm0V50Xcsu4

New research shows lens status (phakic, pseudophakic, or cataract surgery) doesn’t significantly impact glaucoma drainage device success. 👁️ Surgeons can have confidence in GDD outcomes across patient types. Read more: ow.ly/c5qz50XfUJi

Recognize familiar scenarios? Our article, 'A Day in the Life: Glaucoma Specialists,' offers a glimpse into the clinical and academic worlds of glaucoma. A must-read for insights on shared challenges: ow.ly/7xsG50XgwtM

In this special supplement to Glaucoma Today, leaders from Iantrek, PLU Ophthalmics, and more, spotlight some of the most exciting developments redefining the future of ophthalmology and the way clinicians will diagnose, treat, and care for patients: ow.ly/45vA50Xh3Ah

When SLT and drops failed to control IOP in a young glaucoma patient, Dr. Craig Chaya turned to goniotomy—and later, a clear lens extraction with iStent infinite. Watch how this challenging case unfolded 👉 ow.ly/Gxvx50XiySp

With expert, real-world insight from Dr. Christine Funke, discover how the STREAMLINE® Surgical System supports ophthalmic surgeons with intuitive, first-line, implant-free treatment: ow.ly/vtwJ50XlaxK #sponsored @newworldmedical New World Medical

A 68-year-old woman with −19.50 D myopia, 30.5 mm axial length, and advanced glaucoma in her only seeing eye presents a major challenge. How should cataract and IOP be managed in such a “very long eye”? Read more 👇 ow.ly/Fua750XmHUc

In a series of articles, leaders in ophthalmology innovation speak about the future of the field. In Visionary Breakthroughs, experts share their thoughts on the most exciting developments that are redefining the future of glaucoma care. ow.ly/vtif50XnrmA

68-year-old woman with advanced glaucoma in her only eye (−19.5 D, AL 30.5 mm) and zonulopathy. IOP 32 mm Hg on maximal therapy, BCVA 20/80 → 20/30 potential. Would you operate, and which approach suits her risks? Read the full discussion here: ow.ly/WxRF50Xq9uG

Rachel Chapman reviews “Tube Erosion” from Glaucoma Today, covering rates, risks, prevention, and management of this GDI complication. Listen: ow.ly/CbPL50XriB2

Drs. Rachel Simpson and Roya Garakani share their expert perspectives on the iDose TR procedural pharmaceutical. 🎥 Watch now to gain practical pearls for patient selection and implantation: ow.ly/obSB50Xx3ia